 | • レポートコード：QYR9ST04838 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、脂肪肝治療の世界市場について調査・分析し、脂肪肝治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（チアゾリジンジオン、ビタミンE、メトホルミンスタチン、多価不飽和脂肪酸、アンジオテンシン受容体遮断薬、ペントキシフィリン）、用途別（病院および診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の脂肪肝治療市場動向 ・主要企業別マーケットシェア ・脂肪肝治療の種類別市場規模2014-2019 （チアゾリジンジオン、ビタミンE、メトホルミンスタチン、多価不飽和脂肪酸、アンジオテンシン受容体遮断薬、ペントキシフィリン） ・脂肪肝治療の用途別市場規模2014-2019 （病院および診療所、その他） ・脂肪肝治療の北米市場：主要企業・種類別/用途別市場規模 ・脂肪肝治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・脂肪肝治療の中国市場：主要企業・種類別/用途別市場規模 ・脂肪肝治療の日本国内市場：主要企業・種類別/用途別市場規模 ・脂肪肝治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・脂肪肝治療のインド市場：主要企業・種類別/用途別市場規模 ・脂肪肝治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Cardax、Daewoong、Roche、Glenmark、GW、Limerick BioPharma、Merck、Novartis、Orchid、AstraZeneca） ・脂肪肝治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Fatty liver disease is one of the most common liver dysfunction where the triglyceride fat accumulates in liver cells.The major risks associated with fatty liver disease are alcoholic cirrhosis, cardiovascular disorder, metabolic syndrome and biliary cirrhosis among others.
In 2018, the global Fatty Liver Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Fatty Liver Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fatty Liver Treatment development in United States, Europe and China.
The key players covered in this study
Cardax
Daewoong
Roche
Glenmark
GW
Limerick BioPharma
Merck
Novartis
Orchid
AstraZeneca
Market segment by Type, the product can be split into
Thiazolidinedione
Vitamin E
Metformin Statins
Polyunsaturated Fatty Acids
Angiotensin Receptor Blockers
Pentoxifylline
Market segment by Application, split into
Hospitals and Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Fatty Liver Treatment status, future forecast, growth opportunity, key market and key players.
To present the Fatty Liver Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Fatty Liver Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Fatty Liver Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Thiazolidinedione
1.4.3 Vitamin E
1.4.4 Metformin Statins
1.4.5 Polyunsaturated Fatty Acids
1.4.6 Angiotensin Receptor Blockers
1.4.7 Pentoxifylline
1.5 Market by Application
1.5.1 Global Fatty Liver Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Fatty Liver Treatment Market Size
2.2 Fatty Liver Treatment Growth Trends by Regions
2.2.1 Fatty Liver Treatment Market Size by Regions (2014-2025)
2.2.2 Fatty Liver Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Fatty Liver Treatment Market Size by Manufacturers
3.1.1 Global Fatty Liver Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Fatty Liver Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Fatty Liver Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Fatty Liver Treatment Key Players Head office and Area Served
3.3 Key Players Fatty Liver Treatment Product/Solution/Service
3.4 Date of Enter into Fatty Liver Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Fatty Liver Treatment Market Size by Type (2014-2019)
4.2 Global Fatty Liver Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Fatty Liver Treatment Market Size (2014-2019)
5.2 Fatty Liver Treatment Key Players in United States
5.3 United States Fatty Liver Treatment Market Size by Type
5.4 United States Fatty Liver Treatment Market Size by Application
6 Europe
6.1 Europe Fatty Liver Treatment Market Size (2014-2019)
6.2 Fatty Liver Treatment Key Players in Europe
6.3 Europe Fatty Liver Treatment Market Size by Type
6.4 Europe Fatty Liver Treatment Market Size by Application
7 China
7.1 China Fatty Liver Treatment Market Size (2014-2019)
7.2 Fatty Liver Treatment Key Players in China
7.3 China Fatty Liver Treatment Market Size by Type
7.4 China Fatty Liver Treatment Market Size by Application
8 Japan
8.1 Japan Fatty Liver Treatment Market Size (2014-2019)
8.2 Fatty Liver Treatment Key Players in Japan
8.3 Japan Fatty Liver Treatment Market Size by Type
8.4 Japan Fatty Liver Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Fatty Liver Treatment Market Size (2014-2019)
9.2 Fatty Liver Treatment Key Players in Southeast Asia
9.3 Southeast Asia Fatty Liver Treatment Market Size by Type
9.4 Southeast Asia Fatty Liver Treatment Market Size by Application
10 India
10.1 India Fatty Liver Treatment Market Size (2014-2019)
10.2 Fatty Liver Treatment Key Players in India
10.3 India Fatty Liver Treatment Market Size by Type
10.4 India Fatty Liver Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Fatty Liver Treatment Market Size (2014-2019)
11.2 Fatty Liver Treatment Key Players in Central & South America
11.3 Central & South America Fatty Liver Treatment Market Size by Type
11.4 Central & South America Fatty Liver Treatment Market Size by Application
12 International Players Profiles
12.1 Cardax
12.1.1 Cardax Company Details
12.1.2 Company Description and Business Overview
12.1.3 Fatty Liver Treatment Introduction
12.1.4 Cardax Revenue in Fatty Liver Treatment Business (2014-2019)
12.1.5 Cardax Recent Development
12.2 Daewoong
12.2.1 Daewoong Company Details
12.2.2 Company Description and Business Overview
12.2.3 Fatty Liver Treatment Introduction
12.2.4 Daewoong Revenue in Fatty Liver Treatment Business (2014-2019)
12.2.5 Daewoong Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Fatty Liver Treatment Introduction
12.3.4 Roche Revenue in Fatty Liver Treatment Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Glenmark
12.4.1 Glenmark Company Details
12.4.2 Company Description and Business Overview
12.4.3 Fatty Liver Treatment Introduction
12.4.4 Glenmark Revenue in Fatty Liver Treatment Business (2014-2019)
12.4.5 Glenmark Recent Development
12.5 GW
12.5.1 GW Company Details
12.5.2 Company Description and Business Overview
12.5.3 Fatty Liver Treatment Introduction
12.5.4 GW Revenue in Fatty Liver Treatment Business (2014-2019)
12.5.5 GW Recent Development
12.6 Limerick BioPharma
12.6.1 Limerick BioPharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Fatty Liver Treatment Introduction
12.6.4 Limerick BioPharma Revenue in Fatty Liver Treatment Business (2014-2019)
12.6.5 Limerick BioPharma Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Fatty Liver Treatment Introduction
12.7.4 Merck Revenue in Fatty Liver Treatment Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Fatty Liver Treatment Introduction
12.8.4 Novartis Revenue in Fatty Liver Treatment Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 Orchid
12.9.1 Orchid Company Details
12.9.2 Company Description and Business Overview
12.9.3 Fatty Liver Treatment Introduction
12.9.4 Orchid Revenue in Fatty Liver Treatment Business (2014-2019)
12.9.5 Orchid Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Company Details
12.10.2 Company Description and Business Overview
12.10.3 Fatty Liver Treatment Introduction
12.10.4 AstraZeneca Revenue in Fatty Liver Treatment Business (2014-2019)
12.10.5 AstraZeneca Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Fatty Liver Treatment Key Market Segments
Table Key Players Fatty Liver Treatment Covered
Table Global Fatty Liver Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Fatty Liver Treatment Market Size Market Share by Type 2014-2025
Figure Thiazolidinedione Figures
Table Key Players of Thiazolidinedione
Figure Vitamin E Figures
Table Key Players of Vitamin E
Figure Metformin Statins Figures
Table Key Players of Metformin Statins
Figure Polyunsaturated Fatty Acids Figures
Table Key Players of Polyunsaturated Fatty Acids
Figure Angiotensin Receptor Blockers Figures
Table Key Players of Angiotensin Receptor Blockers
Figure Pentoxifylline Figures
Table Key Players of Pentoxifylline
Table Global Fatty Liver Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Others Case Studies
Figure Fatty Liver Treatment Report Years Considered
Table Global Fatty Liver Treatment Market Size 2014-2025 (Million US$)
Figure Global Fatty Liver Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Fatty Liver Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Fatty Liver Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Fatty Liver Treatment Market Share by Regions 2014-2019
Figure Global Fatty Liver Treatment Market Share by Regions 2014-2019
Figure Global Fatty Liver Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Fatty Liver Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Fatty Liver Treatment Market Share by Manufacturers (2014-2019)
Figure Global Fatty Liver Treatment Market Share by Manufacturers in 2018
Table Global Fatty Liver Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Fatty Liver Treatment Product/Solution/Service
Table Date of Enter into Fatty Liver Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Fatty Liver Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Fatty Liver Treatment Market Size Share by Type (2014-2019)
Figure Global Fatty Liver Treatment Market Size Market Share by Type (2014-2019)
Table Global Fatty Liver Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Fatty Liver Treatment Market Size Share by Application (2014-2019)
Figure Global Fatty Liver Treatment Market Size Market Share by Application (2014-2019)
Figure Global Fatty Liver Treatment Revenue Market Share by Application in 2018
Figure United States Fatty Liver Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Fatty Liver Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Fatty Liver Treatment Market Share (2018-2019)
Table United States Fatty Liver Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Fatty Liver Treatment Market Share by Type (2014-2019)
Table United States Fatty Liver Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Fatty Liver Treatment Market Share by Application (2014-2019)
Figure Europe Fatty Liver Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Fatty Liver Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Fatty Liver Treatment Market Share (2018-2019)
Table Europe Fatty Liver Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Fatty Liver Treatment Market Share by Type (2014-2019)
Table Europe Fatty Liver Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Fatty Liver Treatment Market Share by Application (2014-2019)
Figure China Fatty Liver Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Fatty Liver Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Fatty Liver Treatment Market Share (2018-2019)
Table China Fatty Liver Treatment Market Size by Type (2014-20189) (Million US$)
Table China Fatty Liver Treatment Market Share by Type (2014-2019)
Table China Fatty Liver Treatment Market Size by Application (2014-2019) (Million US$)
Table China Fatty Liver Treatment Market Share by Application (2014-2019)
Figure Japan Fatty Liver Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Fatty Liver Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Fatty Liver Treatment Market Share (2018-2019)
Table Japan Fatty Liver Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Fatty Liver Treatment Market Share by Type (2014-2019)
Table Japan Fatty Liver Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Fatty Liver Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Fatty Liver Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Fatty Liver Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Fatty Liver Treatment Market Share (2018-2019)
Table Southeast Asia Fatty Liver Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Fatty Liver Treatment Market Share by Type (2014-2019)
Table Southeast Asia Fatty Liver Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Fatty Liver Treatment Market Share by Application (2014-2019)
Figure India Fatty Liver Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Fatty Liver Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Fatty Liver Treatment Market Share (2018-2019)
Table India Fatty Liver Treatment Market Size by Type (2014-2019) (Million US$)
Table India Fatty Liver Treatment Market Share by Type (2014-2019)
Table India Fatty Liver Treatment Market Size by Application (2014-2019) (Million US$)
Table India Fatty Liver Treatment Market Share by Application (2014-2019)
Figure Central & South America Fatty Liver Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Fatty Liver Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Fatty Liver Treatment Market Share (2018-2019)
Table Central & South America Fatty Liver Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Fatty Liver Treatment Market Share by Type (2014-2019)
Table Central & South America Fatty Liver Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Fatty Liver Treatment Market Share by Application (2014-2019)
Table Cardax Company Details
Table Cardax Revenue in Fatty Liver Treatment Business (2014-2019) (Million US$)
Figure Cardax Revenue Growth Rate in Fatty Liver Treatment Business (2014-2019)
Table Cardax Recent Development
Table Daewoong Company Details
Table Daewoong Revenue in Fatty Liver Treatment Business (2014-2019)(Million US$)
Figure Daewoong Revenue Growth Rate in Fatty Liver Treatment Business (2014-2019)
Table Daewoong Recent Development
Table Roche Company Details
Table Roche Revenue in Fatty Liver Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Fatty Liver Treatment Business (2014-2019)
Table Roche Recent Development
Table Glenmark Company Details
Table Glenmark Revenue in Fatty Liver Treatment Business (2014-2019)(Million US$)
Figure Glenmark Revenue Growth Rate in Fatty Liver Treatment Business (2014-2019)
Table Glenmark Recent Development
Table GW Company Details
Table GW Revenue in Fatty Liver Treatment Business (2014-2019)(Million US$)
Figure GW Revenue Growth Rate in Fatty Liver Treatment Business (2014-2019)
Table GW Recent Development
Table Limerick BioPharma Company Details
Table Limerick BioPharma Revenue in Fatty Liver Treatment Business (2014-2019)(Million US$)
Figure Limerick BioPharma Revenue Growth Rate in Fatty Liver Treatment Business (2014-2019)
Table Limerick BioPharma Recent Development
Table Merck Company Details
Table Merck Revenue in Fatty Liver Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Fatty Liver Treatment Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Fatty Liver Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Fatty Liver Treatment Business (2014-2019)
Table Novartis Recent Development
Table Orchid Company Details
Table Orchid Revenue in Fatty Liver Treatment Business (2014-2019)(Million US$)
Figure Orchid Revenue Growth Rate in Fatty Liver Treatment Business (2014-2019)
Table Orchid Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Fatty Liver Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Fatty Liver Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Global Fatty Liver Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Fatty Liver Treatment Market Size Share by Regions (2019-2025)
Figure Global Fatty Liver Treatment Market Size Share by Regions in 2025
Figure United States Fatty Liver Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Fatty Liver Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Fatty Liver Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Fatty Liver Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Fatty Liver Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Fatty Liver Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Fatty Liver Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Fatty Liver Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Fatty Liver Treatment Market Size by Product (2019-2025)
Figure Global Fatty Liver Treatment Market Size by Product in 2025
Table Global Fatty Liver Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Fatty Liver Treatment Market Size by Application (2019-2025)
Figure Global Fatty Liver Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
非アルコール性脂肪性肝疾患治療の世界市場：市場規模・現状・予測 Fatty liver disease refers to the accumulation of fat (triglycerides,) in the liver. The liver cell contains fats, but the accumulation of excess fat can be a cause of concern and can lead to liver inflammation known as steatohepatitis. The fatty liver can be caused by alcohol as well as can be non-…- 非アルコール性脂肪性肝疾患治療薬の世界市場：市場規模・現状・予測 Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …
- オメガ-3多価不飽和脂肪酸の世界市場：インサイト・予測 Omega−3 fatty acids are polyunsaturated fatty acids. Omega−3 fatty acids are important for normal metabolism.Global omega-3 polyunsaturated fatty acid market is growing at a modest rate due to significant consumption of omega-3 in dietary supplements and pharmaceuticals industries from across the gl…
- 世界のトランス脂肪酸市場：専門的調査 Trans fat, also called trans-unsaturated fatty acids or trans fatty acids, is a type of unsaturated fat that occurs in small amounts in nature, but became widely produced industrially from vegetable fats starting in the 1950s for use in margarine, snack food, packaged baked goods, and for frying fas…
- 牛脂脂肪酸の世界市場：インサイト・予測 Tallow fatty acids are a family of fatty acids derived mainly from animal fat, more particularly of bovine origin. These acids are a mixture of saturated fatty acids (as myristic, palmitic and stearic) and unsaturated (such as palmitoleic, oleic and linoleic).Such acids can be marketed retaining the…